Skip to main content

Advertisement

Log in

Gene delivery of cyclin-dependent kinase inhibitors p21 Waf1 and p27 Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Because tumorigenesis depends on a variety of oncogenes, symphyseal study of combined genes may lead to more significant knowledge about tumorigenesis and progression. Combined deficiency of p21 and p27 proteins in mice is linked to more aggressive spontaneous tumorigenesis. We investigated the effect of the transfected p21 Waf1-p27 Kip1 gene on centrosome duplication, cell proliferation, and apoptosis of MCF-7, a breast cancer cell line.

Methods

The pIRES-p21 Waf1, pIRES-p27 Kip1, and pIRES-p21 Waf1-p27 Kip1 genes were transfected into MCF-7 cells by lipofection. The effect on proliferation was evaluated by MTT assay and clone-formation assay. Cell cycle and apoptosis were analyzed by flow cytometry. Apoptosis was tested by flow cytometry and TUNEL assay. Centrosome duplication was detected by use of indirect immunofluorescence microscopy.

Results

The results showed that the pIRES-p21 Waf1, pIRES-p27 Kip1, and pIRES-p21 Waf1-p27 Kip1 significantly inhibited proliferation of MCF-7 cells, followed by accumulation of MCF-7 cells in cycle G1, induced apoptosis, and a decrease in the proportion of MCF-7 cells which contained abnormal centrosomes. Compared with p21 Waf1 or p27 Kip1 alone, combination of p21 Waf1 and p27 Kip1 had a much more significant effect (P < 0.05).

Conclusion

Altogether, these results indicate that the p21 Waf1-p27 Kip1 gene combination has a more obvious antitumor effect than p21 Waf1 or p27 Kip1 alone. This study provides preclinical evidence that combination of p21 Waf1 and p27 Kip1 could be a novel and promising therapeutic approach to treatment of breast cancer with suppressed p21 Waf1 and p27 Kip1 expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Meraldi P, Nigg EA. The centrosome cycle. FEBS Lett. 2002;521:9–13.

    Article  CAS  PubMed  Google Scholar 

  2. Hinchcliffe EH, Li C, Thompson EA, et al. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science. 1999;283:851–4.

    Article  CAS  PubMed  Google Scholar 

  3. Kataoka TR, Tsukamoto Y, Matsumura M, et al. Expression of p21 Cip1/Waf1 and p27 Kip1 in small cell neuroendocrine carcinoma of the uterine cervix. Int J Surg Pathol. 2008;16:11–5.

    Article  PubMed  Google Scholar 

  4. Kokontis JM, Wagner AJ, O’Leary M, et al. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene. 2001;20:659–68.

    Article  CAS  PubMed  Google Scholar 

  5. Li Y, Dowbenko D, Lasky LA. AKT/PKB phosphorylation of p21 Cip1/WAF1 enhances protein stability of p21 Cip1/WAF1 and promotes cell survival. J Biol Chem. 2002;277:11352–61.

    Article  CAS  PubMed  Google Scholar 

  6. Shibata MA, Yoshidome K, Shibata E, et al. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21 Waf1. Cancer Gene. 2001;8:23–35.

    Article  CAS  Google Scholar 

  7. Lingle WL, Salisbury JL. Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am J Pathol. 1999;155:1941–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Pihan GA, Purohit A, Wallace J, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998;58:3974–85.

    CAS  PubMed  Google Scholar 

  9. Lingle WL, Lutz WH, Ingle JN, et al. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA. 1998;95:2950–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Bloom J, Pagano M. Deregulated degradation of the cdk inhibitor p27 Kip1 and malignant transformation. Semin Cancer Biol. 2003;13:41–7.

    Article  CAS  PubMed  Google Scholar 

  11. Coats S, Flanagen M, Nourse J, et al. Requirement of p27 Kip1 for restriction point control of the fibroblast cell cycle. Science. 1996;272:877–80.

    Article  CAS  PubMed  Google Scholar 

  12. Drexler HCA. The role of p27 Kip1 in proteasome inhibitor induced apoptosis. Cell Cycle. 2003;2:438–41.

    CAS  PubMed  Google Scholar 

  13. Jiang F, Caraway NP, Li R, et al. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene. 2005;24:3409–18.

    Article  CAS  PubMed  Google Scholar 

  14. Chong RF, Li FN, Liu XP, et al. Effects of transfected p21Waf1 gene on the duplication of centrosomes and the proliferation of human breast carcinoma cells. Chin J Exp Surg. 2008;25:12–4.

    Google Scholar 

  15. Kaznelson DW, Bruun S, Monrad A, et al. Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 Waf1 expression induces apoptosis and cathepsin B activation. Virology. 2004;320:301–12.

    Article  CAS  PubMed  Google Scholar 

  16. Saji C, Higashi C, Niinaka Y, et al. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells. Biochem Biophys Res. 2011;415:573–8.

    Article  CAS  Google Scholar 

  17. Seoane J, Le HV, Massague J. Myc suppression of the p21 (Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 2002;419:729–34.

    Article  CAS  PubMed  Google Scholar 

  18. Drexler HC, Pebler S. Inducible p27 (Kip1) expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors. Cell Death Differ. 2003;10:290–301.

    Article  CAS  PubMed  Google Scholar 

  19. García-Fernández RA, García-Palencia P, Sánchez MA, et al. Combined loss of p21waf1/cip1 and p27kip1 enhances tumorigenesis in mice. Lab Invest. 2011;91:1634–42.

    Article  PubMed  Google Scholar 

  20. Ricardo V, Erickson LA, Jin L, et al. p27 kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313–23.

    Article  Google Scholar 

Download references

Acknowledgments

This work was funded by grants from Natural Science Foundation of Shandong Province (y2007C134) and Natural Science Foundation of Qingdao Municipality (06-2-2-5-nsh-1). We thank Dr Zhang for his skillful statistical advice. We also thank Professor Liu from the Central Laboratory, The Affiliated Hospital of Qingdao Medical College, Qingdao University, for her technical support, and colleagues in the laboratory for helpful discussions.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Funian Li.

About this article

Cite this article

Jiang, D., Wang, X., Liu, X. et al. Gene delivery of cyclin-dependent kinase inhibitors p21 Waf1 and p27 Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro. Breast Cancer 21, 614–623 (2014). https://doi.org/10.1007/s12282-012-0438-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-012-0438-y

Keywords

Navigation